Literature DB >> 19352466

Accomplishments in 2007 in the management of localized pancreatic cancer.

Al B Benson1, Malcolm Moore.   

Abstract

Overview of the Disease IncidencePrognostic or Predictive FactorsCurrent General Therapy StandardsAccomplishments During the Year TherapyBiomarkersBasic ScienceWhat Needs To Be Done Applications of the AccomplishmentsControversies and DisagreementsFuture Directions Comments on ResearchObstacles to Progress.

Entities:  

Year:  2008        PMID： 19352466      PMCID： PMC2664916     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


  15 in total

1.  International comparisons of cumulative risk of pancreatic cancer, from cancer incidence in five continents Vol. VIII.

Authors:  Kumiko Saika; Tomohiro Matsuda
Journal:  Jpn J Clin Oncol       Date:  2006-12       Impact factor: 3.019

2.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

3.  Prognostic factors for survival in pancreatic cancer: a population-based study.

Authors:  Mohamad A Eloubeidi; Renee A Desmond; C Mel Wilcox; Reda J Wilson; Pavan Manchikalapati; Mona M Fouad; Isam Eltoum; Selwyn M Vickers
Journal:  Am J Surg       Date:  2006-09       Impact factor: 2.565

4.  Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.

Authors:  Sunil Krishnan; Vishal Rana; Nora A Janjan; James L Abbruzzese; Morris S Gould; Prajnan Das; Marc E Delclos; Shana Palla; Sushovan Guha; Gauri Varadhachary; Douglas B Evans; Robert A Wolff; Christopher H Crane
Journal:  Cancer       Date:  2006-12-01       Impact factor: 6.860

5.  Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.

Authors:  Florence Huguet; Thierry André; Pascal Hammel; Pascal Artru; Jacques Balosso; Frédéric Selle; Elisabeth Deniaud-Alexandre; Philippe Ruszniewski; Emmanuel Touboul; Roberto Labianca; Aimery de Gramont; Christophe Louvet
Journal:  J Clin Oncol       Date:  2007-01-20       Impact factor: 44.544

6.  Survival and prognostic factors of unresectable pancreatic cancer.

Authors:  Joo Kyung Park; Yong Bum Yoon; Yong-Tae Kim; Ji Kon Ryu; Won Jae Yoon; Sang Hyub Lee
Journal:  J Clin Gastroenterol       Date:  2008-01       Impact factor: 3.062

7.  Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer.

Authors:  Hisao Wakabayashi; Yoshihiro Nishiyama; Tsuyoshi Otani; Takanori Sano; Shinichi Yachida; Keiichi Okano; Kunihiko Izuishi; Yasuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

8.  Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.

Authors:  V Heinemann; R Labianca; A Hinke; C Louvet
Journal:  Ann Oncol       Date:  2007-07-28       Impact factor: 32.976

9.  Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals.

Authors:  Karl Y Bilimoria; David J Bentrem; James S Tomlinson; Ryan P Merkow; Andrew K Stewart; Clifford Y Ko; Jay B Prystowsky; Mark S Talamonti
Journal:  Am J Surg       Date:  2007-11       Impact factor: 2.565

10.  Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.

Authors:  Thomas Zacharias; Daniel Jaeck; Elie Oussoultzoglou; Agnes Neuville; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.